INTRA-CELLULAR THERAPI

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

19 Nov 2024 08:00:53 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

11 Nov 2024 09:45:08 By NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

07 Nov 2024 09:48:04 By NetDania Notify

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

07 Nov 2024 08:00:18 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

06 Nov 2024 09:45:14 By NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

05 Nov 2024 15:06:30 By NetDania Notify

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

05 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

30 Oct 2024 09:50:43 By NetDania Notify

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

30 Oct 2024 07:30:35 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

17 Oct 2024 08:00:33 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

23 Sep 2024 08:00:34 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

28 Aug 2024 08:00:04 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

08 Aug 2024 08:00:26 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

07 Aug 2024 07:40:54 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

07 Aug 2024 07:30:38 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

24 Jul 2024 08:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

18 Jun 2024 07:30:16 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

10 Jun 2024 08:00:34 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

29 May 2024 08:00:54 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

23 May 2024 08:00:00 By Nasdaq GlobeNewswire